Plain-English guides on GLP-1 medications and men’s health, written from law and peer-reviewed research, with every source listed. Reviewed every quarter.
A plain explanation of sections 503A and 503B, what each is allowed to do, who inspects them, and how to check which one is making your medication.
6 min readCompounded semaglutide is still being sold after the 2025 deadlines. Here is the legal argument that allows it, the pressure it is under, and what to ask.
6 min readTrimix is a compounded injection for erectile dysfunction. What is in it, how well injection therapy works, and what not being FDA approved actually means.
8 min readThe honest answer on compounded semaglutide safety: what the FDA has documented, what the research shows, and the one number people quote wrongly.
7 min readCompounded tirzepatide safety, without the sales pitch: the FDA's documented concerns, the adverse event count, and why its timeline ran ahead of semaglutide's.
6 min readSemaglutide sold as a research chemical or without a prescription is a different category again. What testing has found in those products, and why the label matters.
6 min readWegovy and Zepbound compared on mechanism, trial results, side effects and 2026 cost. Includes the head to head trial that put them directly against each other.
8 min readThe two molecules behind the leading weight loss brands, compared on mechanism, trial results, cardiovascular evidence and side effects, with sources.
7 min readOzempic and Wegovy both contain semaglutide but are approved for different things at different doses. Why the distinction matters for coverage and for what you are told.
6 min readOrforglipron is an oral GLP-1 approved in 2026 under the brand Foundayo. What the trials found, how it compares to the injections, and the boxed warning.
6 min readCompounded semaglutide and Ozempic are not the same product. What differs, what the FDA says you cannot be told, and why Ozempic may be the wrong comparison anyway.
7 min readCompounded tirzepatide and Zepbound compared: what the FDA reviewed and what it did not, the missing evidence, and how the 2026 price changes altered the maths.
6 min readPlatelet-rich plasma injections for erectile dysfunction have been tested against placebo in randomised trials. Here is what those trials actually reported.
7 min readInjection therapy for erectile dysfunction has been in use since the 1980s. What it is, how well it works, the risks, and how it differs from newer injectables.
7 min readVacuum erection devices are a non-drug option for erectile dysfunction with systematic review evidence and international consultation recommendations behind them.
6 min readWhy compounded GLP-1s undercut the brands, what changed in 2026 when federal pricing arrived, and how to work out which route is actually cheapest for you.
7 min readMedicare, Medicaid, federal cash pricing and commercial insurance compared, with the eligibility test for each and the fine print nobody prints.
9 min readCMS offers certain GLP-1 drugs at fifty dollars a month to eligible Part D beneficiaries through 2027. The dates, the drugs, the eligibility and the fine print.
6 min readMedicare now covers certain GLP-1 drugs for weight management through a CMS demonstration at fifty dollars a month. What changed, when, and what still is not covered.
6 min readMedicaid coverage of GLP-1 drugs for weight management is a state by state decision. How to find out for your state, and what changes from 2027.
5 min readWhat a GLP-1 costs if you have no coverage, including the federal cash prices launched in 2026 and how they compare to compounded and grey market options.
7 min readWhy plans deny weight management drugs, what prior authorisation actually asks for, how to appeal, and the brand distinction that decides a lot of claims.
7 min read